Tang Capital Management’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.3M | Buy |
897,616
+130,676
| +17% | +$3.83M | 1.33% | 22 |
|
|
2025
Q1 | $19.7M | Hold |
766,940
| – | – | 1.09% | 25 |
|
|
2024
Q4 | $22.1M | Hold |
766,940
| – | – | 1.47% | 17 |
|
|
2024
Q3 | $18.2M | Buy |
766,940
+19,324
| +3% | +$459K | 1.3% | 21 |
|
|
2024
Q2 | $12.9M | Buy |
747,616
+200,000
| +37% | +$3.46M | 1.32% | 25 |
|
|
2024
Q1 | $12.2M | Buy |
547,616
+191,647
| +54% | +$4.28M | 1.27% | 25 |
|
|
2023
Q4 | $6.53M | Buy |
355,969
+67,880
| +24% | +$1.24M | 0.6% | 40 |
|
|
2023
Q3 | $5M | Sell |
288,089
-9,857
| -3% | -$171K | 0.71% | 43 |
|
|
2023
Q2 | $5.42M | Buy |
297,946
+8,165
| +3% | +$149K | 0.8% | 36 |
|
|
2023
Q1 | $4.97M | Buy |
289,781
+132,638
| +84% | +$2.27M | 0.74% | 42 |
|
|
2022
Q4 | $3.65M | Hold |
157,143
| – | – | 0.53% | 46 |
|
|
2022
Q3 | $3.49M | Hold |
157,143
| – | – | 0.43% | 51 |
|
|
2022
Q2 | $3.03M | Buy |
+157,143
| New | +$3.03M | 0.46% | 42 |
|